Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU industry responds to Lalis' letter and latest MDD (Medical Devices Directive) review text

This article was originally published in Clinica

Executive Summary

Eucomed, the European medical technology industry association, is disappointed that many of the issues that it has flagged as priorities in the context of the review of the Medical Devices Directive (MDD) have seemingly not been taken up by the Commission in the latest text of the proposed review. Although this text had still not been published as Clinica went to press, Commission director, Georgette Lalis, who oversees medical device legislation, has recently written a letter to those who responded to the public consultation on the review concerning the outcome of that consultation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT056860

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel